drugset / Press release

Novo Nordisk A/S: Tresiba® (insulin degludec) godkendt i Japan

2012-09-28 · Novo Nordisk A/S · original novonordisk.com ↗

Degludec · regulatory Insulin · regulatory insulin degludec · regulatory regular insulin

Novo Nordisk meddelte i dag, at det japanske ministerium for sundhed, arbejde og velfærd har godkendt Tresiba® (insulin degludec) til behandling af diabetes. Yderligere information: Medier: Investorer: Mike Rulis Kasper Roseeuw Poulsen Tlf. 3079 3573 Tlf. 4442 4303 [email protected] [email protected] Frank Daniel Mersebach Tlf. 4442 0604 [email protected] Lars Borup Jacobsen Tlf. 3075 3479 [email protected] Selskabsmeddelelse nr. 59 / 2012

The release as fetched from its publisher. novonordisk.com ↗